Related Experiment Video
Updated: Jan 29, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Construction and validation of nomogram prediction model for anxiety and depression in chemotherapy patients with
Liping Wu1, Yizhen Li2, Hui Li3
1Department of pharmacy, Ganzhou People's Hospital, Ganzhou, Jiangxi, China.
Objective:
To construct and validate a nomogram prediction model for anxiety and depression in chemotherapy patients with multiple myeloma (MM).
Methods:
From May 2021 to May 2023, 333 MM chemotherapy patients treated at our hospital were selected. The patients were randomly divided into a modeling group and a validation group in a 7:3 ratio (using a random number table method). According to whether the modeling group patients had anxiety and depression, they were grouped into a non-anxiety and depression group and an anxiety and depression group; a nomogram model constructed using R software was built to evaluate the predictive performance of the model. Clinical decision curves (DCA) were used to assess the value of the clinical application of the model.
Results:
Out of the 233 patients in this study, 66 experienced anxiety and depression, with an incidence rate of 28.33%. There were great differences in gender, economic income, education level, tumor staging, complications, and treatment plans between the anxiety and depression group and the non-anxiety and depression group (P<0.05). The results of multivariate Logistic regression analysis showed that gender, education level, tumor stage, complications, and treatment plan were risk factors for anxiety and depression in MM chemotherapy patients (P<0.05), while economic income served as a protective factor (P<0.05). The AUC of the modeling group was 0.945, and the H-L test was χ2 = 8.579, P = 0.674, with good agreement. The AUC of the validation group was 0.967, and the H-L test was χ2 = 7.315, P = 0.698, with good consistency. The DCA curve shows that the probability of assessing anxiety and depression in patients undergoing MM chemotherapy is higher for clinical use when the probability is between 0.05 and 0.95.
Conclusion:
Gender, education, tumor stage, comorbidities and treatment regimen were risk factors for anxiety and depression in MM chemotherapy patients, while financial income was a protective factor for anxiety and depression in MM chemotherapy patients, and the constructed nomogram visually predicted the risk of anxiety and depression in MM chemotherapy patients.
Related Concept Videos
01:29Reliability and Validity
01:05Long-term Depression
01:18Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
03:12Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
01:28Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
01:23Dosage Regimen Designs: Nomograms and Tabulations